Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Fissolo N, Pignolet B, Matute-Blanch C, Trivino JC, et al. MMP9 is decreased in natalizumab-treated MS patients at risk for PML. Ann Neurol 2017 Jul 6. doi: 10.1002/ana.24987.
PMID: 28681388


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016